PATENT CLAIM ANALYSIS

Application Number: 15771648
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "204100"]

Abstract:
Safe, rapid and efficient methods for producing antigen-specific T cells recognizing human papilloma virus or HPV antigens.

Claim (Index 30):
A kit comprising:\n i. T cells and T cell precursor cells that have been separated from dendritic cells and dendritic precursor cells and that are na\u00efve to an HPV peptide antigen, ii. cytokines including but not limited to at least one of IL-2, IL-6, IL-7, IL-12, and IL-15, iii. a medium that maintains the viability of said T cells and T-cell precursor cells; iv. dendritic or dendritric precursor cells that have been separated from said T cells and T cell precursor cells, v. a medium that maintains the viability of said dendritic or dendritic precursor cells; vi. K562 cells or other non-autologous cells that costimulate T cells, optionally treated to prevent outgrowth, and vii. at least one HPV peptide antigen or mixture of HPV peptides.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 91.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15885197', '15331659', '14364592', '10222960', '12271576']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7464867272594506
- 35 USC 102 Novelty (BERT): 0.5274413007107672
- Combined Prediction Score: 0.7245821846045823
- Mean Citation Score: 294.7064400000001
- Max Citation Score: 344.2144
- Similarity Product: 234.825140896988

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test